ORGO
Organogenesis Holdings Inc.
Key Financials
Operating Income
$44.7M
↑ 3583.6%
Revenue
$564.2M
↑ 17.0%
Gross Profit
$366.3M
↑ 12.1%
Net Income
$37.0M
↑ 4201.0%
EPS (Diluted)
$0.15
↑ 1600.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ORGO |
| Company Name | Organogenesis Holdings Inc. |
| CIK | 1661181 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 781-575-0775 |